Contact Information
Company Information
Company
Immunic Therapeutics
Annual Revenue
37500000.0
Technologies
Outlook
Apache
Mobile Friendly
Etracker
WordPress.org
Piwik
Basis
Data Analytics
Keywords
healthcare
biotechnology
life sciences
biotechnology: pharmaceutical preparations
health care
biotechnology research
immunology
oral therapies
chronic inflammatory diseases
autoimmune diseases
vidofludimus calcium
imu-856
imu-381
clinical trials
multiple sclerosis
celiac disease
ulcerative colitis
therapeutic efficacy
safety & tolerability
small molecule modulators
neuroprotective effects
dihydroorotate dehydrogenase
dhodh inhibition
sirtuin 6
sirt6
gastrointestinal diseases
intestinal barrier function
regeneration of bowel epithelium
immune response
clinical development
phase 3 trials
phase 2 trials
first-in-class
weight management
patient needs
therapeutic options
chronic conditions
pharmaceutical industry
biopharmaceuticals
research & development
dosage forms
patient-friendly
health outcomes
innovation
drug development
clinical data
medical research
therapeutics
biotech solutions
transformative healthcare
chronic disease management
patient care strategies
safety profiles
medical therapies
health technology
health
wellness & fitness
hospital & health care
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans